2-(2,2-dicyclopropylethenyl)-5-[(2R,3R)-2-(1-methylimidazol-2-yl)oxan-3-yl]-1,3,4-oxadiazole
C19H24N4O2 — CID 154801621
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(2,2-dicyclopropylethenyl)-5-[(2R,3R)-2-(1-methylimidazol-2-yl)oxan-3-yl]-1,3,4-oxadiazole
2-(2,2-dicyclopropylethenyl)-5-[(2R,3R)-2-(1-methylimidazol-2-yl)oxan-3-yl]-1,3,4-oxadiazole (PubChem CID 154801621) has the molecular formula C19H24N4O2 and a molecular weight of 340.43 g/mol. Its IUPAC name is 2-(2,2-dicyclopropylethenyl)-5-[(2R,3R)-2-(1-methylimidazol-2-yl)oxan-3-yl]-1,3,4-oxadiazole.
Molecular Properties
| Compound Name | 2-(2,2-dicyclopropylethenyl)-5-[(2R,3R)-2-(1-methylimidazol-2-yl)oxan-3-yl]-1,3,4-oxadiazole |
|---|---|
| PubChem CID | 154801621 |
| Molecular Formula | C19H24N4O2 |
| Molecular Weight | 340.43 g/mol |
| Exact Mass | 340.19 |
| IUPAC Name | 2-(2,2-dicyclopropylethenyl)-5-[(2R,3R)-2-(1-methylimidazol-2-yl)oxan-3-yl]-1,3,4-oxadiazole |
| SMILES | Cn1ccnc1[C@@H]1OCCC[C@H]1c1nnc(C=C(C2CC2)C2CC2)o1 |
| InChI | InChI=1S/C19H24N4O2/c1-23-9-8-20-18(23)17-14(3-2-10-24-17)19-22-21-16(25-19)11-15(12-4-5-12)13-6-7-13/h8-9,11-14,17H,2-7,10H2,1H3/t14-,17-/m1/s1 |
| InChIKey | PGHNZTJYMGETHP-RHSMWYFYSA-N |
| XLogP | 3.64 |
| TPSA | 65.97 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 340.43 |
| LogP ≤ 5 | 3.64 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154801621 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.